Discover
ACOG
Alpha Cognition Inc. Common Stock
7.79
7 x 7.60
1 x 6.50
bid
ask
+
0.57
7.89%
4 @ 04:15 AM
7.79 +0.00 (0.00%)
| Ytd | 19.85% | |
| 1y | -15.33% |
6.90
day range
7.99
4.50
52 week range
11.54
| Open | 7.19 | Prev Close | 7.22 | Low | 6.90 | High | 7.99 | Mkt Cap | 169.62M |
| Vol | 33.13K | Avg Vol | 44.00K | EPS | -1.39 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 6.23 | 200-d Avg | 6.21 | 1yr Est | 0.00 |
ACOG News
benzinga.com
Alpha Cognition Appoints Robert Wills As Board Chairman, Succeeding Len Mertz
Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition", or the "Company"), a biophar
benzinga.com
Alpha Cognition Enrolls First Patient In RESOLVE, Phase 4 Post-Marketing Clinical Study To Further E
Alpha Cognition, Inc. (ACOG: NASDAQ) ("Alpha Cognition" or the "Company"), a biophar
benzinga.com
Alpha Cognition Reports Top-Line Results From BEACON Real-World Study Of ZUNVEYL
Providers reported cognitive improvement in 92% of patients following initiation of ZUNVEYLProvider